PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapyLidija Antunovic, Martina Sollini, Rita De Sanctis et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 150
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer PatientsRita De Sanctis, Armando Santoro, Elisa Agostinetto et al.|Oncology|2018Cited by 20
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyPaola Tiberio, Rita De Sanctis, Chiara Miggiano et al.|Nutrients|2023Cited by 7
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective CohortFabrizia Gelardi, Martina Sollini, Lara Cavinato et al.|Diagnostics|2024Cited by 5
Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient CohortFabrizia Gelardi, Lidija Antunovic, Paola Tiberio et al.|Cancers|2025Cited by 3